Navigation Links
Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
Date:5/20/2008

oterol fumarate) Inhalation Solution, the first and only FDA-approved nebulized formoterol fumarate, were also recently published. Perforomist(TM) Inhalation Solution is indicated for long-term, twice-daily maintenance treatment of COPD.

-- "Efficacy and Safety of Formoterol Fumarate Delivered by Nebulization

to COPD Patients," published in the February 2008 issue of Respiratory

Medicine, detailed pivotal Phase III data that supported the NDA

approval for Perforomist(TM) (formoterol fumarate) Inhalation Solution.

The study demonstrated that Perforomist(TM) Inhalation Solution has a

rapid onset of significant bronchodilation within five minutes of

administration and is safe and effective. The study assessed the

efficacy and safety of Perforomist(TM) Inhalation Solution in 351

adults with moderate-to-severe COPD. Nicholas J. Gross, MD, PhD, Hines

VA Hospital, Stricht Loyola School of Medicine, was lead author and

principal investigator of the study.

-- In October 2007, Clinical Therapeutics published cardiac safety results

from the Phase III trial for Perforomist(TM) Inhalation Solution. In

"Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A

12-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-

and Active-Controlled Trial," the data showed that Perforomist(TM)

Inhalation Solution was associated with rapid and sustained improvement

in pulmonary function with no clinically significant cardiac effects,

including QT prolongation, increased proarrhythmic events, or changes

in serum potassium levels. Harold S. Nelson, MD, Professor of

Medicine, National Jewish Medical and Research Center; was lead author

of the article and principal investigator of the study. Patients with

cardiac problems were excluded from the study. Perforom
'/>"/>

SOURCE Dey, L.P.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
2. Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
3. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
4. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
5. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
6. Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
7. Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
8. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
9. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
10. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
11. Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Sony Biotechnology Inc. ("Sony") today announced the launch of ... be exhibiting and taking orders for this system at ... San Diego Convention Center in ... - 22.  The SP6800 Spectral Analyzer ... into new and novel functionalities for the immunology, oncology, ...
(Date:5/17/2013)...  TechAtlas Group has announced the release of ... for the Chronic Kidney Disease (CKD) market. This ... drugs and devices currently on the market and ... (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) ... renal denervation , diabetic nephropathy - antifibrotics ...
(Date:5/17/2013)... PONCE , Puerto Rico , May ... southern, central and western Puerto Rico , ... , PR) Center has improved its radiation therapy capabilities with ... in Puerto Rico . Versa HD offers ... wide range of tumors throughout the body, while also enabling ...
Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2
... 11, 2007 /PRNewswire-FirstCall/ - Paul S.,Aisen, M.D., ... Medical Center, and principal investigator in the ... III clinical trial,for tramiprosate (ALZHEMED(TM)) will present ... for the treatment of,Alzheimer's disease (AD). The ...
... /PRNewswire/ -- Sugammadex -,the novel selective relaxant binding ... business unit of Akzo Nobel -,demonstrated in a ... of neuromuscular blockade as compared to neostigmine,without evidence ... muscle relaxation.(1),(2) The results of this,pivotal Aurora trial ...
Cached Medicine Technology:At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 3Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial as Compared to Neostigmine 4
(Date:5/20/2013)... 20, 2013 Milpitas, Los Angeles, ... leader in enterprise-class information archiving, eDiscovery and migration ... 7.0, the latest release in the MessageSolution product ... the legal discovery lifecycle. MessageSolution will exhibit at ... CA. , As the first stop of the ...
(Date:5/20/2013)... InVite® Health, a leading nutraceutical firm ... of its new Greens Hx™ product; a ... with plant extracts from 39 super foods including sea ... pectin, plant enzymes and non-dairy probiotics. A small ... levels of several servings of vegetables. The product is ...
(Date:5/20/2013)... May 20, 2013 The transvaginal mesh ... device law firm, report that two important bellwether trials ... in state and federal litigations established for C.R. Bard ... the first C.R. Bard bellwether trial will begin in ... of West Virginia. (In re: C.R. Bard, Inc., ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Today is ... Perfect Interview Answers Webinar tomorrow. Job seekers ... Career Confindential’s expert career coach, will show job seekers ... Webinar attendees will also learn the perfect interview answers ... as interview techniques that will get them hired. Job ...
(Date:5/19/2013)... California has one of the largest pool of ... discovering that comprehensive background checks are playing an important role ... Driving records can paint an accurate portrait of a ... any DUI arrests, speeding offenses, and traffic violations to their ... to experience 4SafeDrivers.com, a new online service which allows users ...
Breaking Medicine News(10 mins):Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4Health News:Today Is the Last Day to Register for Tomorrow’s Perfect Interview Answers Webinar From Career Confidential 2Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2
... ANN ARBOR, Mich.---Apparently your mom had it right when she ... talked dirty. Lying really does create a desire to clean ... study. "The references to ,dirty hands, or ,dirty mouths, ... of moral purity in terms of more concrete experiences with ...
... at the Indiana University Melvin and Bren Simon Cancer ... show that changes in brain tissue can occur in ... of chemotherapy, often referred to as "chemobrain," have been ... the first to use brain imaging to study women ...
... , CHAPEL HILL, N.C. -- A team of UNC ... National Cancer Institute,s Cancer Nanotechnology Platform Partnerships to address ... effective treatments for pancreatic cancer. Wenbin Lin, PhD, ... MD, assistant professor of surgery and pharmacology, are the ...
... between the increase in sales of new antidepressants in recent ... a study based on figures from the Nordic countries, researchers ... that increased sales of the new medicines could be linked ... find any relationship between reduced sales of the older and ...
... UN Millennium Development Goals (MDG) summit in New York ... the eight goals agreed in 2000 on alleviating world ... to a close, governments, businesses and aid organisations made ... emphasis on improving maternal and child health. A global ...
... Reporter , TUESDAY, Sept. 28 (HealthDay News) -- Think recess, ... break in the school day set aside for running and ... adult life. What if your workplace started offering recess on ... a good idea but possibly one of the most solid ...
Cached Medicine News:Health News:Dirty hands, dirty mouths: U-M study finds a need to clean the body part that lies 2Health News:IU researchers: Chemotherapy alters brain tissue in breast cancer patients 2Health News:Decrease in suicide not linked to newer antidepressants 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 3Health News:Adding Recess to the Workday Gains Backers 2Health News:Adding Recess to the Workday Gains Backers 3Health News:Adding Recess to the Workday Gains Backers 4
The entirely open modular system is especially suitable for stereotactic microsurgical procedures....
Used to negotiate tortuous vessels....
The Emerald Guidewire is intended for percutaneous introduction of catheters....
... The MULTI-LINK VISION Coronary Stent System is ... cobalt chromium stents. Cobalt chromium is stronger ... a cobalt chromium stent can have similar ... steel stent with struts that are only ...
Medicine Products: